Propanc Biopharma's Joint Research Partner Pushing Boundarie

MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering

Related Keywords

Amsterdam , Noord Holland , Netherlands , Melbourne , Victoria , Australia , James Nathanielsz , Propanc Biopharma , Toledo Cutillas , Elisa Giovanetti , Julian Kenyon , Umc University Medical Centers , Company Mechanism Of Action , Cancer Center Amsterdam , Drug Administration , Molecular Oncology Laboratory , Propanc Biopharma Inc , University Medical Centers , Cancer Center , Professor Elisa Giovanetti , Professor Giovanetti , Chief Scientific Officer , Drug Designation , Private Securities Litigation Reform Act , Press Release , ,